By using this site, you agree to our updated
Cookie and Privacy Policy
.
Skip to content
Resources
News & Events
About Us
简
WuXi Biology
Drug Discovery Services
Analytical Services
Purification and Structure Elucidation
Physicochemical Characterization & Compound Validation
Pharmaceutical Analysis and Quality Control
Mass Spectrometry Services
Hit Finding and Screening Services
AS-MS Screening
DNA-Encoded Library (DEL)
Fragment Screening & FBDD
High-throughput Screening (HTS)
Virtual Screening
Integrated Drug Discovery
Integrated Platforms
Project Management
Discovery Chemistry
Structure Based Drug Discovery
Protein Production
FBDD – Fragment Screening
Biophysical Assays and Screening
Biopharmaceutical Assays
CryoEM
X-ray Crystallography
Biology Services
Gene Manipulation
AAV Vector Services
Gene Editing Services
Target Discovery Services
Structural Biology
Protein Production
FBDD – Fragment Screening
Biophysical Assays and Screening
X-ray Crystallography
CryoEM
Microscale Thermophoresis
Biophysical Assays for Drug-Target Interactions
in vitro Biology
Assay Development
Biochemical Assays
Immune and Cell-Based Assays
In vitro Toxicology and Safety Pharmacology
Screening
in vivo Pharmacology
Cardiovascular Diseases Models
CNS Models
Fibrosis Disease Models
Inflammation Models
Kidney Disease Models
Liver Disease Models
Pain Models
Tumor Models
Oncology and Immunology
CRISPR/Cas9 Gene Editing
Tumor Models
Immuno-oncology
Cancer Cell Panel & In Vitro Oncology Assays
Translational Oncology
Immune profiling | Biomarker platforms
OncoWuXi Database
Solutions
Phase
Target Identification and Validation
Hit Finding
Hit to Lead
Lead Optimization
Candidate Selection
IND Submission
Platforms
Structure Based Drug Discovery
Screening Platform
Biology Platforms
In Vitro Biology
Pharmacology Studies
Toxicology Platform
Drug Metabolism and Pharmacokinetics
Translational Platform
Biomarker Platform
Therapeutic Areas
Autoimmune and Inflammatory Diseases
Cardiovascular & Metabolic Diseases
Central Nervous System and Pain
Infectious Diseases
Liver Diseases
Oncology & Immuno-oncology
Respiratory Diseases
Therapeutic Modalities
Antibody Drug Conjugate
CAR-T Cell Therapy
Natural Products
Oligonucleotides
Peptides
Targeted Protein Degradation
Resources
News & Events
About Us
Contact Us
Contact Us
Tumor evolution selectively inactivates the core microRNA machinery for immune evasion
Nat Communications_2021
Download
← Return to Resources
Clear Filter
Resource Topics
Therapeutic Areas
Therapeutic Modalities
Stages
Technology Platforms
in vitro Biology
Screening Services
Resource Types
